Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia
intervention
Impact of Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia
1 other identifier
interventional
40
1 country
1
Brief Summary
Objective: The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, were included into ; group (A) received low intensity laser therapy, inspiratory muscle training in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 6, 2026
CompletedFirst Submitted
Initial submission to the registry
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
April 27, 2026
April 1, 2026
2 months
April 15, 2026
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
IgG
Immunoglobulin-G (mg/dl)
at baseline and after one month
IgA
Immunoglobulin-A(mg/dl)
at baseline and after one month
IgM
Immunoglobulin-M (mg/dl)
at baseline and after one month
WBCs
White blood cells (thousands/mm3)
at baseline and after one month
Secondary Outcomes (2)
RR
at baseline and after one month
SaO2
at baseline and after one month
Study Arms (2)
group (A)
EXPERIMENTALreceived low intensity laser therapy, inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment at a frequency of 3 sessions per week for one month
group (B)
EXPERIMENTALreceived inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
Interventions
low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements
received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
Eligibility Criteria
You may qualify if:
- Dawn Syndrome children with pneumonia
- Mean age of 3.73±1.82 year
- Children were in the first attack of bronchopneumonia.
You may not qualify if:
- Other chest disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Badr Universitylead
Study Sites (1)
Mona Mohamed Abdelkhalek
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mona Mohamed Abdelkhalek, assistance prof
Badr University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistance professor
Study Record Dates
First Submitted
April 15, 2026
First Posted
April 27, 2026
Study Start
April 6, 2026
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
May 30, 2026
Last Updated
April 27, 2026
Record last verified: 2026-04